DTC Ad Risk Disclosures Could Be Limited To ‘Serious And Actionable’
Executive Summary
Despite PhRMA’s concerns, FDA is proceeding with a study using modified versions of existing TV ads, but agency will revise study questions to focus on value of the ‘major statement’ and not other aspects of ads.